These medical spas were offering compounded versions of GLP-1s, marketing them as just as safe and effective as the versions approved by the Food and Drug Administration according to Yost
C.GambardellaA.di MauroG.et al (2022)
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al
After 24 weeks, the magnesium group exhibited a mean cortisol decrease of 32nmol, leading the researchers to conclude that magnesium supplementation could be a "potential mechanism" by which to lower one's risk of cardiovascular disease stemming from high cortisol.73 Magnesium comes in numerous forms, each bound to a different compound that informs its stability, absorptivity, and health effects
Studies of efinopegdutide, another dual GLP-1/GCGR agonist, have shown preliminary efficacy